Home » Newsletters » BioWorld Asia

BioWorld Asia

May 10, 2000

View Archived Issues

Fluorescence Method Could Allow Rapid Screening For Cancer Drugs

Merger Between Vanguard, CeNeS Appears To Be Off

Computer Modeling Technology Aids Synergix In Drug Discovery

EU Implements New Rules Governing Orphan Drugs

PowderJect Presents 2 Studies Showing Validity Of Technology

Scotia Stock Falls Following Report Of Burns From Foscan

British Biotech Uses Expertise To Land Deal With ImmunoGen

Actelion Completes Phase III Study Of Hypertension Drug

Oxford GlycoSciences Publishes Results, Files For Protein Patents

Australia Academics Creating Two New Biotech Institutes

TVM Closes EUR300M Fund For Seed And Start-Up Firms

Tm Bioscience Boosts Genomics Reach Through Deal On Biochips

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...